HUP0302912A2 - Béta-tio-aminosavak, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Béta-tio-aminosavak, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0302912A2 HUP0302912A2 HU0302912A HUP0302912A HUP0302912A2 HU P0302912 A2 HUP0302912 A2 HU P0302912A2 HU 0302912 A HU0302912 A HU 0302912A HU P0302912 A HUP0302912 A HU P0302912A HU P0302912 A2 HUP0302912 A2 HU P0302912A2
- Authority
- HU
- Hungary
- Prior art keywords
- unsubstituted
- singly
- unsaturated
- saturated
- multiply substituted
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 6
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
A találmány (I) általános képletű b-tio-a-aminosavakra[mely képletbenR1 és R2 jelentése egymástól függetlenül hidrogénatom; egyenes vagyelágazó láncú, telített vagy telítetlen, helyettesítetlen vagyegyszeresen vagy többszörösen helyettesített 1-10 szénatomos alkil-csoport; benzil-, aril-, 3-8 szénatomos cikloalkil- vagy heteroaril-csoport, mimellett e csoportok helyettesítetlenek vagy egyszeresenvagy többszörösen helyettesítve lehetnek; vagy R1 és R2 együtttelített vagy telítetlen, helyettesített vagy helyettesítetlen (CH2)3-6-gyűrűt képeznek, amelyben 0-2 szénatom helyén kénatom, oxigénatomvagy NR4 atom lehet jelen; R4 jelentése hidrogénatom; telített vagytelítetlen, egyenes vagy elágazó láncú, helyettesítetlen vagyegyszeresen vagy többszörösen helyettesített 1-10 szénatomosalkilcsoport; R3 jelentése hidrogénatom; telített vagy telítetlen,egyenes vagy elágazó láncú, helyettesítetlen vagy egyszeresen vagytöbbszörösen helyettesített 1-10 szénatomos alkilcsoport; telítettvagy telítetlen, helyettesítetlen vagy egyszeresen vagy többszörösenhelyettesített 3-8 szénatomos cikloalkilcsoport; helyettesítetlen vagyegyszeresen vagy többszörösen helyettesített aril- vagy heteroaril-csoport; vagy telített vagy telítetlen 1-3 szénatomos alkil-csoportonkeresztül kapcsolódó aril-, 3-8 szénatomos cikloalkil- vagyheteroaril-csoport, mimellett e csoportok helyettesítetlenek vagyegyszeresen vagy többszörösen helyettesítve lehetnek] e vegyületekelőállítására, az e vegyületeket tartalmazó gyógyászati készítményekreés a tioaminosavaknak gyógyszerek előállítására történőfelhasználására vonatkozik. Ó
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10045831A DE10045831A1 (de) | 2000-09-14 | 2000-09-14 | Thio-Aminosäuren |
DE10049484A DE10049484A1 (de) | 2000-09-29 | 2000-09-29 | ß-Thioaminosäuren |
PCT/EP2001/010488 WO2002022568A1 (de) | 2000-09-14 | 2001-09-11 | β-THIO-AMINOSÄUREN |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0302912A2 true HUP0302912A2 (hu) | 2003-12-29 |
HUP0302912A3 HUP0302912A3 (en) | 2005-05-30 |
Family
ID=26007074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302912A HUP0302912A3 (en) | 2000-09-14 | 2001-09-11 | Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them |
Country Status (16)
Country | Link |
---|---|
US (1) | US6846843B2 (hu) |
EP (1) | EP1317426B1 (hu) |
JP (1) | JP2004509101A (hu) |
AR (1) | AR030662A1 (hu) |
AT (1) | ATE309983T1 (hu) |
AU (2) | AU2002214978B2 (hu) |
CA (1) | CA2421990C (hu) |
DE (1) | DE50108104D1 (hu) |
DK (1) | DK1317426T3 (hu) |
ES (1) | ES2252310T3 (hu) |
HU (1) | HUP0302912A3 (hu) |
MX (1) | MXPA03002090A (hu) |
NZ (1) | NZ525143A (hu) |
PE (1) | PE20020426A1 (hu) |
PL (1) | PL361424A1 (hu) |
WO (1) | WO2002022568A1 (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NI200300043A (es) | 2002-03-28 | 2003-11-05 | Warner Lambert Co | AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA. |
US7659305B2 (en) | 2002-10-31 | 2010-02-09 | Pfizer Inc. | Therapeutic proline derivatives |
CA2509605C (en) | 2002-12-13 | 2010-10-05 | Warner-Lambert Company Llc | Alpha-2-delta ligand to treat lower urinary tract symptoms |
CA2451267A1 (en) | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
ATE449633T1 (de) | 2003-09-12 | 2009-12-15 | Pfizer | Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern |
BRPI0414819A (pt) | 2003-09-25 | 2006-11-14 | Warner Lambert Co | pró-fármacos de aminoácidos com afinidade para a proteìna alfa2delta |
EA017171B1 (ru) | 2006-12-22 | 2012-10-30 | Рекордати Айерленд Лимитед | КОМБИНИРОВАННАЯ ТЕРАПИЯ ЗАБОЛЕВАНИЙ НИЖНИХ МОЧЕВЫВОДЯЩИХ ПУТЕЙ С ИСПОЛЬЗОВАНИЕМ ЛИГАНДОВ αδ И НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ (НПВП) |
TW200908957A (en) * | 2007-06-15 | 2009-03-01 | Xenoport Inc | Use of prodrugs of GABA analogs, antispasticity agents, and prodrugs of GABAB receptor agonists for treating spasticity |
WO2009045556A1 (en) * | 2007-10-05 | 2009-04-09 | Peter Coppola | Treatment method for revitalizing hair and method of producing keratin protein treatment solution |
US8785370B2 (en) | 2007-10-05 | 2014-07-22 | Keratin Complex Holdings, Inc. | Reactive keratin protein formulations and methods of using for revitalizing hair |
EP2449076B1 (en) | 2009-06-30 | 2016-09-21 | Basf Se | Aqueous alkaline cleaning compositions and methods of their use |
US8927476B2 (en) | 2010-07-19 | 2015-01-06 | Basf Se | Aqueous alkaline cleaning compositions and methods of their use |
US10047042B2 (en) | 2013-11-01 | 2018-08-14 | Glytech, Inc. | Method for producing D-form or L-form amino acid derivative having thiol group |
WO2024022998A1 (en) * | 2022-07-26 | 2024-02-01 | Inke, S.A. | Process for preparing daprodustat and cocrystals thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3091569A (en) * | 1960-08-26 | 1963-05-28 | Mead Johnson & Co | Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus |
NL144484B (nl) | 1967-07-26 | 1975-01-15 | Merck & Co Inc | Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren. |
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
HUT40447A (en) | 1984-03-29 | 1986-12-28 | Sandoz Ag | Process for preparing substituted alpha-amino acids and pharmaceutical compositions containing such compounds |
DE3727897A1 (de) * | 1987-08-21 | 1989-03-02 | Degussa | Verfahren zur herstellung von n-acylierten mercapto-(alpha)-aminosaeuren |
DE3821540A1 (de) * | 1988-06-25 | 1989-12-28 | Boehringer Mannheim Gmbh | Neue sulfonamide, verfahren zu ihrer herstellung sowie solche sulfonamide enthaltende arzneimittel |
JPH0659399A (ja) * | 1992-08-10 | 1994-03-04 | Konica Corp | ハロゲン化銀カラー写真感光材料用発色現像処理錠剤 |
US5401839A (en) * | 1993-03-23 | 1995-03-28 | Lever Brothers Company, Division Of Conopco, Inc. | Process of preparing N-substituted aldonamides having improved color and color stability |
US6620848B2 (en) * | 1997-01-13 | 2003-09-16 | Smithkline Beecham Corporation | Nitric oxide synthase inhibitors |
GB9808667D0 (en) * | 1998-04-23 | 1998-06-24 | Merck Sharp & Dohme | Therapeutic compounds |
US6245801B1 (en) * | 1998-09-14 | 2001-06-12 | Warner-Lambert Company | Branched alkyl pyrrolidine-3-carboxylic acids |
AU1602100A (en) * | 1998-11-25 | 2000-06-13 | Warner-Lambert Company | Improved gamma amino butyric acid analogs |
US6225311B1 (en) * | 1999-01-27 | 2001-05-01 | American Cyanamid Company | Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
PT1154993E (pt) * | 1999-02-18 | 2005-01-31 | Hoffmann La Roche | Derivados de tioamida |
AU5971300A (en) * | 1999-06-08 | 2000-12-28 | Peter Prehm | Rheumatic autoimmune disease antigen |
US6642398B2 (en) * | 1999-06-10 | 2003-11-04 | Warner-Lambert Company | Mono-and disubstituted 3-propyl gamma-aminobutyric acids |
BR0014090A (pt) * | 1999-09-16 | 2002-05-21 | Warner Lambert Co | Método para rastreamento de ligandos de ligação à subunidade alfa2delta-1 |
-
2001
- 2001-09-11 NZ NZ525143A patent/NZ525143A/en unknown
- 2001-09-11 AU AU2002214978A patent/AU2002214978B2/en not_active Ceased
- 2001-09-11 JP JP2002526821A patent/JP2004509101A/ja not_active Withdrawn
- 2001-09-11 CA CA002421990A patent/CA2421990C/en not_active Expired - Fee Related
- 2001-09-11 PL PL36142401A patent/PL361424A1/xx unknown
- 2001-09-11 ES ES01983480T patent/ES2252310T3/es not_active Expired - Lifetime
- 2001-09-11 EP EP01983480A patent/EP1317426B1/de not_active Expired - Lifetime
- 2001-09-11 HU HU0302912A patent/HUP0302912A3/hu unknown
- 2001-09-11 WO PCT/EP2001/010488 patent/WO2002022568A1/de active IP Right Grant
- 2001-09-11 DE DE50108104T patent/DE50108104D1/de not_active Expired - Lifetime
- 2001-09-11 AU AU1497802A patent/AU1497802A/xx active Pending
- 2001-09-11 DK DK01983480T patent/DK1317426T3/da active
- 2001-09-11 AT AT01983480T patent/ATE309983T1/de active
- 2001-09-11 MX MXPA03002090A patent/MXPA03002090A/es active IP Right Grant
- 2001-09-12 AR ARP010104311A patent/AR030662A1/es not_active Application Discontinuation
- 2001-09-13 PE PE2001000921A patent/PE20020426A1/es not_active Application Discontinuation
-
2003
- 2003-03-14 US US10/387,843 patent/US6846843B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1317426A1 (de) | 2003-06-11 |
ES2252310T3 (es) | 2006-05-16 |
JP2004509101A (ja) | 2004-03-25 |
AU2002214978B2 (en) | 2006-08-31 |
US20030236253A1 (en) | 2003-12-25 |
PL361424A1 (en) | 2004-10-04 |
EP1317426B1 (de) | 2005-11-16 |
CA2421990C (en) | 2009-11-03 |
PE20020426A1 (es) | 2002-05-18 |
ATE309983T1 (de) | 2005-12-15 |
US6846843B2 (en) | 2005-01-25 |
AR030662A1 (es) | 2003-08-27 |
WO2002022568A1 (de) | 2002-03-21 |
NZ525143A (en) | 2005-12-23 |
DE50108104D1 (de) | 2005-12-22 |
DK1317426T3 (da) | 2006-01-09 |
MXPA03002090A (es) | 2003-06-19 |
AU1497802A (en) | 2002-03-26 |
CA2421990A1 (en) | 2003-03-12 |
HUP0302912A3 (en) | 2005-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302912A2 (hu) | Béta-tio-aminosavak, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0300148A2 (en) | Dipeptide nitrile cathepsin k inhibitors, process for their preparation and pharmaceutical compositions containing them | |
ATE71375T1 (de) | Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen. | |
HUP0401537A2 (hu) | Tiohidantoin-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására | |
HUP0302962A2 (hu) | Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása | |
HUP0001285A2 (hu) | Proteáz inhibitor hatású pirrolidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP9802323A2 (hu) | Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények | |
FI946073A0 (fi) | Vitamiini D-sarjan, 20-asemassa modifioituja johdannaisia, menetelmä tällaisten johdannaisten valmistamiseksi, menetelmässä käytettäviä välituotteita, mainittuja johdannaisia sisältäviä farmaseuttisia valmisteita ja johdannaisten käyttö lääkeaineiden valmistamiseen | |
HUP9802937A2 (hu) | Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk | |
HUP9802517A2 (hu) | Foszfonsavval helyettesített benzazepinon-N-ecetsav-származékok, eljárás ezek előállítására és az e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0400832A2 (hu) | Új amido-alkil-piperidin- és amido-alkil-piperazin-származékok, és ilyen származékokat hatóanyagként tartalmazó gyógyszerkészítmények | |
DE3777544D1 (de) | Glutaminsaeure-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische formulierungen. | |
AR036176A1 (es) | Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado | |
TNSN07395A1 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0401082A2 (hu) | Helyettesített 4-amino-ciklohexanolok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ES2102043T3 (es) | Derivados de 22-en-25-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que los contienen, asi como su utilizacion en calidad de medicamentos. | |
ATE8401T1 (de) | Anthracyclin-glycoside, verfahren zu ihrer herstellung, zwischenprodukte und ihre herstellung und arzneimittel. | |
HUP0303195A2 (hu) | O-helyettesített-6-metil-tramadol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0302970A2 (hu) | Aminosavak felhasználása fájdalom kezelésére, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE107298T1 (de) | 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
TR200101083T2 (tr) | (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim. | |
HUP0401773A2 (hu) | [(2-Amino-3,4-dioxo-1-ciklobutén-1-il)-amino]-alkánsav-származékok alkalmazása fájdalom kezelésére alkalmas gyógyszerkészítmények előállítására | |
DE60041137D1 (de) | Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel | |
DE50301507D1 (de) | 17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |